Replimune Group, Inc. (REPL) › Operating IncomeReplimune Group, Inc. (REPL) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2017: -$9.65M2018: -$19.23M2019: -$30.95M2020: -$56.20M2021: -$79.95M2022: -$118.31M2023: -$177.08M2024: -$234.77M2025: -$261.63M-$261.63M2017Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$261.63M-11.4%2024-$234.77M-32.6%2023-$177.08M-49.7%2022-$118.31M-48.0%2021-$79.95M-42.3%2020-$56.20M-81.6%2019-$30.95M-60.9%2018-$19.23M-99.3%2017-$9.65M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share